New Nordic Healthbrands Stock Working Capital
| NNH Stock | SEK 14.90 0.20 1.36% |
New Nordic Healthbrands fundamentals help investors to digest information that contributes to New Nordic's financial success or failures. It also enables traders to predict the movement of New Stock. The fundamental analysis module provides a way to measure New Nordic's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to New Nordic stock.
New |
New Nordic Healthbrands Company Working Capital Analysis
New Nordic's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current New Nordic Working Capital | 32 M |
Most of New Nordic's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, New Nordic Healthbrands is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Based on the company's disclosures, New Nordic Healthbrands has a Working Capital of 32 M. This is 92.48% lower than that of the Healthcare sector and 93.25% lower than that of the Drug Manufacturers - Specialty & Generic industry. The working capital for all Sweden stocks is 97.84% higher than that of the company.
New Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses New Nordic's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of New Nordic could also be used in its relative valuation, which is a method of valuing New Nordic by comparing valuation metrics of similar companies.New Nordic is currently under evaluation in working capital category among its peers.
New Fundamentals
| Return On Equity | -0.0316 | |||
| Return On Asset | -0.0058 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | (0) % | |||
| Current Valuation | 221.83 M | |||
| Shares Outstanding | 6.2 M | |||
| Shares Owned By Insiders | 48.28 % | |||
| Price To Earning | 17.52 X | |||
| Price To Book | 1.56 X | |||
| Price To Sales | 0.36 X | |||
| Revenue | 514.85 M | |||
| Gross Profit | 350.05 M | |||
| EBITDA | 29.48 M | |||
| Net Income | 21.3 M | |||
| Cash And Equivalents | 11.88 M | |||
| Cash Per Share | 3.16 X | |||
| Total Debt | 1.24 M | |||
| Debt To Equity | 0.80 % | |||
| Current Ratio | 1.92 X | |||
| Book Value Per Share | 18.74 X | |||
| Cash Flow From Operations | (7.87 M) | |||
| Earnings Per Share | 1.91 X | |||
| Number Of Employees | 70 | |||
| Beta | 0.67 | |||
| Market Capitalization | 184.62 M | |||
| Total Asset | 238.35 M | |||
| Retained Earnings | 32 M | |||
| Working Capital | 32 M | |||
| Current Asset | 130 M | |||
| Current Liabilities | 98 M | |||
| Z Score | 91.4 | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 238.35 M | |||
| Last Dividend Paid | 1.25 |
About New Nordic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze New Nordic Healthbrands's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of New Nordic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of New Nordic Healthbrands based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for New Stock Analysis
When running New Nordic's price analysis, check to measure New Nordic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy New Nordic is operating at the current time. Most of New Nordic's value examination focuses on studying past and present price action to predict the probability of New Nordic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move New Nordic's price. Additionally, you may evaluate how the addition of New Nordic to your portfolios can decrease your overall portfolio volatility.